Tryptase Inhibition Blocks Airway Inflammation in a Mouse Asthma Model
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Release of human lung mast cell tryptase may be important in the pathophysiology of asthma. We examined the effect of the reversible, nonelectrophilic tryptase inhibitor MOL 6131 on airway inflammation and hyper-reactivity in a murine model of asthma. MOL 6131 is a potent selective nonpeptide inhibitor of human lung mast cell tryptase based upon a β-strand template (Ki = 45 nM) that does not inhibit trypsin (Ki = 1,061 nM), thrombin (Ki = 23, 640 nM), or other serine proteases. BALB/c mice after i.p. OVA sensitization (day 0) were challenged intratracheally with OVA on days 8, 15, 18, and 21. MOL 6131, administered days 18–21, blocked the airway inflammatory response to OVA assessed 24 h after the last OVA challenge on day 22; intranasal delivery (10 mg/kg) had a greater anti-inflammatory effect than oral delivery (10 or 25 mg/kg) of MOL 6131. MOL 6131 reduced total cells and eosinophils in bronchoalveolar lavage fluid, airway tissue eosinophilia, goblet cell hyperplasia, mucus secretion, and peribronchial edema and also inhibited the release of IL-4 and IL-13 in bronchoalveolar lavage fluid. However, tryptase inhibition did not alter airway hyper-reactivity to methacholine in vivo. These results support tryptase as a therapeutic target in asthma and indicate that selective tryptase inhibitors can reduce allergic airway inflammation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Schwartz, L. B., Yunginger, J. W., Miller, J., Bokhari, R., & Dull, D. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114051 · Cited by 456 · cited 1×
“The serine protease tryptase, localized in mast cell granules, constitutes up to 25% of the total mast cell protein (1, 2) and may play a key role in the pathogenesis of asthma and other allergic disorders (3, 4).”
BackgroundCharacterization of genes encoding known and novel human mast cell tryptases on chromosome 16p13.3
Pallaoro, M., Fejzo, M. S., Shayesteh, L., Blount, J. L., & Caughey, G. H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.6.3355 · Cited by 146 · cited 1×
“-tryptase are not the equivalents of mMCP-6 and mMCP-7 (56, 57), and although mMCP-6 and mMCP-7 exhibit homologies with human -tryptase (57), the true orthologues may await discovery (58).”
Background
Cited by
Mast cell tryptases and chymases in inflammation and host defense.
Caughey, G. H. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00509.x · Cited by 442
“Although details of the mechanism of direct tryptase-mediated mitogenesis remain to be worked out, the likelihood that they play a role in asthma-associated airway remodeling is high given the nature of the in vitro observations, demonstration of tryptase release in asthmatic airways (87), and effects of tryptase inhi…”
BackgroundMethodMast cell proteases: multifaceted regulators of inflammatory disease
Pejler, G., Rönnberg, E., Waern, I., & Wernersson, S. (2010) · Blood · doi:10.1182/blood-2010-01-257287 · Cited by 378
Pejler, G., Åbrink, M., Ringvall, M., & Wernersson, S. (2007) · Advances in Immunology · doi:10.1016/s0065-2776(07)95006-3 · Cited by 320
Tryptase genetics and anaphylaxis
Caughey, G. H. (2006) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2006.02.026 · Cited by 150
Choi, J.-M., Ahn, M.-H., Chae, W.-J., Jung, Y.-G., Park, J.-C., Song, H.-M., Kim, Y.-E., Shin, J.-A., Park, C.-S., Park, J.-W., et al. (2006) · Nature Medicine · doi:10.1038/nm1385 · Cited by 138
Self-citation
Metadata
- Authors
- Oh, S.-W., Pae, C. I., Lee, D.-K., Jones, F., Chiang, G. K. S., Kim, H.-O., Moon, S.-H., Cao, B., Ogbu, C., Jeong, K.-W., Kozu, G., Nakanishi, H., Kahn, M., Chi, E. Y., & Henderson, W. R.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-02
- Volume
- 168
- Issue
- 4
- Pages
- 1992-2000
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2119241961
- Cited by
- 131
- References
- 2
- FWCI
- 5.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.